Pharmalot

Pharmalot By Ed Silverman

This academic published a manual for using a little-known federal law for lowering drug prices

Pharmalot By Ed Silverman

FTC sues drug makers over allegedly illegal deal over an opioid painkiller

Pharmalot By Ed Silverman

Pharmalittle: Regeneron says its antibody prevented Covid-19 in a trial; EU threatens to impose vaccine export controls

Pharmalot By Ed Silverman

European Ombudsman probes failure to disclose Covid-19 vaccine contracts

Pharmalot By Ed Silverman

Pharmalittle: Merck halts development of Covid-19 vaccines; Moderna starts work on booster shot to combat variants

Pharmalot By Ed Silverman

Up and down the ladder: The latest comings and goings

Pharmalot By Ed Silverman

Pharmalittle: Pfizer agrees to supply Covid-19 vaccine to WHO Covax program; FDA approves first injectable HIV medicine

Pharmalot By Ed Silverman

FDA approves first monthly injectable to treat HIV infection

Pharmalot By Ed Silverman

Canada’s drug makers rattle their sabers over a government plan to control medicine spending

Pharmalot By Ed Silverman

Pharmalittle: Lilly says its antibody prevented Covid-19 in a trial; EU and Pfizer clash over vaccine delays

Pharmalot By Ed Silverman

The CEO of Mark Cuban’s generics company talks drug prices, manufacturing, and his famous boss

Pharmalot By Ed Silverman

How much? Hospitals mark up some medicines by 250% on average

Pharmalot By Ed Silverman

Pharmalittle: Pfizer and BioNTech say vaccine is effective against Covid-19 variant; U.S. to join COVAX initiative

Pharmalot By Ed Silverman

Pharmalittle: U.S. health officials seek more use of Covid-19 antibody drugs; Pfizer to reduce vaccine supplies to Europe

Pharmalot By Ed Silverman

Family medicine residents don’t interact with pharma as much as they once did

Pharmalot By Ed Silverman

Will the FTC get tougher on pharma business practices under the Biden administration?

Pharmalot By Ed Silverman

Maryland Senate overrides governor’s veto of prescription drug affordability board

Pharmalot By Ed Silverman

Up and down the ladder: The latest comings and goings

Pharma By Ed Silverman

Pharmalittle: Biden taps Kessler to lead Operation Warp Speed; Trump administration seeks term limits on top FDA, CDC scientists

Pharmalot By Ed Silverman

Medicare Part D spent twice what the VA paid for the same drugs

Pharma By Ed Silverman

Drug makers sue HHS over a discount program serving low-income populations

Pharmalot By Ed Silverman

Pharmalittle: J&J Covid-19 vaccine data show some immunity after one dose; Biden may tap Sharfstein to run the FDA

Pharmalot By Ed Silverman

Former Merck employee arrested for stealing trade secrets on cancer research

Pharmalot By Ed Silverman

Mark Cuban wades into the generic drug shark tank with a new company

Pharmalot By Ed Silverman

Pharmalittle: J&J Covid-19 vaccine production is behind schedule; Slaoui resigns from Operation Warp Speed

Pharmalot By Ed Silverman

Endocrinologists urge federal lawmakers to act to lower insulin costs

Pharmalot By Ed Silverman

Pharmalittle: Pfizer to boost Covid-19 vaccine production; HHS overrules FDA on its top lawyer pick

Pharmalot By Ed Silverman

The prices of 7 drugs were hiked without proof of new benefits, costing the U.S. $1.2 billion in 2019

Pharmalot By Ed Silverman

Commerce Department agency proposes eliminating ‘march-in rights’ as a tool to lower drug prices